Tuesday, January 15, 2013

Partnerships 2013 delivers disruptive innovation practices from out of industry experts

Current business models are unraveling and the pharmaceutical industry is in the midst of an unprecedented renaissance of openness and collaboration. Seismic shifts in clinical development are required to keep up with the pace.

Disruptive innovation is the bridge on your roadmap to clinical trial innovation.

At Partnerships in Clinical Trials 2013, industry thought leaders equip you with the strategies to act as a catalyst in your organization with a focus on open innovation, cross-pharma pre-competitive information sharing and out of industry insights to evoke change.

Never before has a group of disruptive innovation experts come together in one place to remove the barriers for progress and push clinical development forward:
  • ● Eric Topol MD, Director, Scripps Translational Science Institute, Distinguished Physician, Genomist and Author of The Creative Destruction of Medicine
  • ● James Heywood, Co-founder and Chairman, PatientsLikeMe
  • ● Terry Jones, Founder, Travelocity.com, Chairman, Kayak.com, and former Chief Information Officer, American Airlines/Sabre, Author, The Business of Innovation
For more information on these sessions and the rest of the agenda, download the brochure.

In order to innovate the clinical trial landscape, collaboration across departments is required. The Partnerships 2013 agenda provides more proven value than ever before. As a reader of this blog, you and your colleagues can receive 15% off the standard rate when you register to join us April 21-24, 2013 in Orlando, Florida. If you have any questions or need more information, feel free to email Jennifer Pereira.




No comments: